Macy's (NYSE: M) raised its full-year guidance across every major metric after a second quarter that beat both top- and bottom-line estimates. The lift came from a rare trifecta: positive comparable sales across all three nameplates.
Net sales rose 1.1% to $4.9 billion, edging past the $4.81 billion consensus. Comparable sales climbed 2.7%, well ahead of the 0.5%–1.2% range the company had guided for the full year just three months ago. Adjusted diluted EPS of $0.63 nearly doubled the $0.37 estimate, though $0.23 of that came from a net tariff refund benefit. Excluding the refund, adjusted EPS still rose 14% year-over-year to $0.40.
The headline number is Bloomingdale's. Comparable sales surged 11.3%, the brand's second consecutive quarter of double-digit growth and its highest Q2 sales volume ever. This is not a blip. Bloomingdale's is now running at a pace that would make it a standalone growth story. Bluemercury added 6.2% comps, and even the flagship Macy's nameplate posted a 1.1% comp gain, its fifth straight quarter of positive comparable sales. The Reimagine 200 stores within Macy's did 1.9%.
Gross margin expanded 180 basis points to 41.5%. That number is almost entirely a tariff refund story: the 180bp expansion matches the 180bp benefit from net tariff refunds. Strip that out, and underlying gross margin was up just 10bp, with ongoing tariff and fuel costs eating 10bp. The underlying picture is one of modest improvement, not a step-change in pricing power.
SG&A as a percentage of total revenue improved 20bp to 38.7%, but absolute SG&A rose $16 million to $1.96 billion, driven by variable costs on higher sales and investments in the Bold New Chapter strategy. The company is spending to win, and so far the returns justify the outlay.
The guidance raise is the real story here, and it is unambiguous. Full-year net sales now expected at $21.675B–$21.825B, up from $21.5B–$21.75B. Comparable sales growth raised to 1.0%–1.5% from 0.5%–1.2%. Adjusted EBITDA margin lifted to 7.8%–8.0% from 7.7%–7.9%. Adjusted EPS raised to $2.15–$2.35 from $2.00–$2.20. Every metric moved up.
But the guidance also reveals management's caution. The company explicitly notes that the full-year guide incorporates reinvestment of the majority of tariff refunds, with only about $0.05 per share flowing through to adjusted EPS. The $0.23 benefit in Q2 is partly offset by $0.18 of reinvestment in the second half. This is a management team choosing to fund growth rather than pocket the windfall. That is the right call if the investments work, but it means the Q2 beat is not a clean read-through for the rest of the year.
Shareholder returns remain a fixture. Macy's repurchased $50 million in shares during Q2, bringing the first-half total to $100 million, with $1.0 billion remaining under its $2.0 billion authorization. The quarterly dividend of $0.1915 was declared. The balance sheet is comfortable: $1.3 billion in cash, $2.4 billion in total debt, and no material maturities until 2030.
The forward watch is whether Bloomingdale's momentum can sustain and whether the Reimagine 200 stores continue to outperform the broader Macy's fleet. The guidance raise suggests management sees enough demand visibility to commit. But the tariff refund structure means the second half faces a tougher comparison on margin, and the company's own reinvestment plans will compress the benefit. Macy's is executing well, but the Q2 beat is partly a timing story on refunds. The underlying operating improvement is real, if incremental.